For the Inventor, By the Inventor

Enter assignee name

Knoxville, TN, United States of America

Provectus Pharmatech, Inc

Calculating rank

USPTO Granted Patents = 26

% Expired Patents = 34.6

CIPO Patents = 1

EPO Patents = 8

Forward Citations = 90

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Eric A Wachter (24 out of 48 patents)

H Craig Dees (13 out of 31 patents)

Timothy C Scott (11 out of 31 patents)

4. Jamie Singer (9 out of 12 patents)

5. Aru Narendran (8 out of 8 patents)

6. Dominic Rodrigues (6 out of 6 patents)

7. John T Smolik (6 out of 13 patents)

8. Satbir Thakur (5 out of 5 patents)

9. Lucy Swift (5 out of 5 patents)

10. Chunfen Zhang (5 out of 5 patents)

11. Mohit Jain (5 out of 6 patents)

12. Walter G Fisher (5 out of 17 patents)

13. Edward V Pershing (4 out of 4 patents)

14. Bruce Horowitz (4 out of 4 patents)

15. Craig J Eagle (3 out of 4 patents)

Core Competencies:

Halogenated Xanthene

Topical Anti-Bacterial

Ophthalmic Composition

Anti-Tumor Activity

Hematologic Cancers

Immunomodulative Therapies

Photodynamic Treatment

Chemotherapeutic Medicaments

Diagnostic Agents

Radiolabeled Compounds

Systemic Therapies

Pediatric Solid Tumors

26 patents: Sort by Forward Citations

1. 12661335 - Halogenated xanthene-containing topical anti-gram-positive bacterial ophthalmic composition and method (2026-06-23),

2. 12377068 - In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors (2025-08-05),

3. 12133840 - Halogenated xanthene composition and method for treating hematologic cancers (2024-11-05),

4. 12064507 - Composition and method for oral treatment of leukemia (2024-08-20),

5. 11975106 - Uses of halogenated xanthenes in oncology and virology (2024-05-07),

6. 11974980 - In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors (2024-05-07),

7. 11938182 - Halogenated xanthenes as vaccine adjuvants (2024-03-26),

8. 11426379 - Combination of local and systemic therapies for enhanced treatment of dermatologic conditions (2022-08-30),

9. 11419844 - Halogenated xanthene composition and method for treating hematologic cancers (2022-08-23),

10. 11071781 - Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer (2021-07-27),

11. 11058664 - In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors (2021-07-13),

12. 10471144 - Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer (2019-11-12),

13. 10130658 - Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small molecule ablative compound (2018-11-20),

14. 9839688 - Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer (2017-12-12),

15. 9808524 - Combination of local and systemic immunomodulative therapies for melanoma and liver cancer (2017-11-07),

Company Overview

Provectus Pharmatech, Inc. is a biotechnology company based in Knoxville, TN, specializing in the development of innovative therapies for various medical conditions. The organization focuses on advancing its proprietary drug delivery systems and formulations, particularly in the fields of oncology and dermatology. By leveraging cutting-edge research and technology, Provectus aims to enhance treatment efficacy and improve patient outcomes, contributing to the evolving landscape of pharmaceutical solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

26 Patents

#7 in Knoxville, TN

#126 in Tennessee

#12,874 in US

#24,847 in the World

Knoxville, TN, United States of America

Provectus Pharmatech, Inc

Forward Citations = 90

25 inventors:

Eric A Wachter (24 out of 48 patents)

H Craig Dees (13 out of 31 patents)

Timothy C Scott (11 out of 31 patents)

4. Jamie Singer (9 out of 12 patents)

5. Aru Narendran (8 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Provectus Pharmatech, Inc. Retrieved from https://idiyas.com/company/provectus-pharmatech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…